In this context, a recent study indicates a relevant role of TRL signaling in the progression of NAFLD and NASH, revealing NASH patients’ higher prevalence of Small intestinal bacterial overgrowth (SIBO), which is associated with enhanced expression of TLR-4 in the liver [170]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatohepatitis.